These two brief webcasts provide background to the COPD Assessment Test (CAT)—a short, simple, validated questionnaire for measuring health status in COPD patients. The CAT can be used alongside measures such as lung function to give a more complete picture of how COPD affects a patient.
By using the CAT patients should be better able to describe the impact COPD has on them. Healthcare professionals should then have greater patient insight to support optimisation of patient care.
Introduction to the COPD Assessment Test
Practical use of the COPD Assessment Test in clinical practice
At the end of each webcast you will be able to print out a certificate, which will provide you with evidence of your learning.
These webcasts were originally developed for and hosted by www.eGuidelines.co.uk in September 2010. Allen & Hanburys supported the development of the webcasts.
Click here to register free of charge for www.eGuidelines.co.uk and access further information on COPD.
The above mentioned webcasts were developed by MGP Ltd and funded by Allen & Hanburys, the Specialist Respiratory Division of GlaxoSmithKline UK. Allen & Hanburys had no editorial input other than reviewing the material for scientific accuracy and ABPI code compliance. The development of the COPD Assessment Test was funded by GlaxoSmithKline group of companies. COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies. ©2009 GlaxoSmithKilne group of companies. All rights reserved.
No part of this publication may be reproduced in any form without the permission of MGP Ltd.
Page Last Updated: April 25, 2012
COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
